V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10374899 | 10071141 | 1.85 | 68.25 | null | 2017-10-19 | 2022-04-20 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101121401 |
| 10374966 | 10071142 | null | 0 | null | 2022-05-08 | 2022-05-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | ACALABRUTINIB | 101219231 |
| 10375153 | 10071143 | 1.62 | 63.6 | Palliative (P) | 2019-11-12 | 2020-09-11 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 101125657 |
| 10376546 | 10071146 | 1.7 | 87.4 | null | 2018-06-25 | 2018-07-03 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | CETUXIMAB | 101359054 |
| 10378276 | 10071148 | 1.69 | 64.4 | 03 | 2020-10-22 | 2020-11-02 | Vinorelbine (oral) | 02 | N | ACALABRUTINIB | 100452186 |
| 10379136 | 10071152 | null | 52.4 | null | 2019-03-26 | 2019-03-26 | CISPLATIN + GEMCITABINE | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101684977 |
| 10379774 | 10071155 | 1.7 | null | null | 2019-05-08 | 2020-02-23 | CTD Attenuated (Thalidomide 50mg) | 02 | null | DABRAFENIB | 101333127 |
| 10380023 | 10071156 | 1.82 | 0 | null | 2021-09-13 | 2022-04-24 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100643928 |
| 10380491 | 10071158 | 1.7 | 70.3 | Palliative (P) | 2022-03-26 | 2022-03-26 | DABRAFENIB | 02 | N | CISPLATIN + VINORELBINE | 100357870 |
| 10380513 | 10071159 | 1.52 | 45.1 | null | 2017-02-03 | 2017-02-07 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101129962 |
| 10381113 | 10071161 | 1.72 | 93.4 | 02 | 2018-10-27 | 2018-10-27 | IPILIMUMAB + NIVOLUMAB | N | N | BUSULFAN | 101216699 |
| 10382031 | 10071164 | 1.72 | 88.5 | Palliative (P) | 2020-01-04 | 2020-01-11 | GEMCITABINE | 02 | N | GEMCITABINE | 101623011 |
| 10383158 | 10071166 | 1.71 | 61.4 | 03 | 2020-04-20 | 2020-04-22 | Azacitidine | 02 | Y | AZACITIDINE | 100700369 |
| 10383758 | 10071168 | 1.76 | 96.2 | null | 2017-06-03 | 2018-04-04 | Acalabrutinib | 02 | null | CISPLATIN | 100732005 |
| 10383819 | 10071169 | null | 91 | Palliative (P) | 2020-10-05 | 2020-10-05 | Palbociclib | 02 | N | PALBOCICLIB | 100441465 |
| 10384006 | 10071171 | 1.71 | 80.2 | null | 2018-02-06 | 2018-02-08 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CISPLATIN + VINORELBINE | 101054517 |
| 10384319 | 10071172 | 1.8 | 57 | 03 | 2020-01-16 | 2020-01-17 | Cetuximab 14 day | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100176167 |
| 10385524 | 10071174 | 1.79 | 107.9 | 03 | 2020-02-21 | 2020-02-26 | null | 02 | N | CAPECITABINE + IRINOTECAN | 100116411 |
| 10385774 | 10071175 | 1.86 | 91.4 | Palliative (P) | 2021-09-09 | 2021-09-25 | AFATINIB | 02 | null | AFATINIB | 101162058 |
| 10386123 | 10071176 | 1.82 | null | Curative (C) | 2018-06-12 | 2018-06-12 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101063711 |
| 10386259 | 10071177 | 1.62 | 71 | null | 2020-01-18 | 2020-02-03 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 100045841 |
| 10386670 | 10071178 | 1.78 | 66 | Palliative (P) | 2019-03-12 | 2019-06-29 | FLUOROURACIL + RT | 02 | N | CABOZANTINIB | 101070837 |
| 10387807 | 10071181 | 1.85 | 74.8 | null | 2018-08-27 | 2019-03-27 | Acalabrutinib | 02 | null | NIRAPARIB | 100494608 |
| 10388018 | 10071182 | 1.66 | 87.7 | null | 2019-03-28 | 2019-04-03 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101054566 |
| 10388184 | 10071183 | 1.74 | 89.35 | null | 2022-02-06 | 2022-02-11 | Trifluridine + Tipiracil | 99 | null | TIPIRACIL + TRIFLURIDINE | 100641963 |
| 10388212 | 10071184 | 1.68 | 65.45 | null | 2022-03-27 | 2022-03-30 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100539760 |
| 10388440 | 10071186 | 1.59 | 72.3 | 03 | 2020-12-29 | 2021-01-26 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101539323 |
| 10388558 | 10071187 | 1.68 | 60 | null | 2019-06-01 | 2019-06-01 | CARBOPLATIN + VINORELBINE | 02 | null | CARBOPLATIN + VINORELBINE | 100157464 |
| 10388828 | 10071188 | 1.69 | 71 | Adjuvant (A) | 2020-04-12 | 2020-05-02 | CABOZANTINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100260280 |
| 10389303 | 10071189 | 1.57 | null | Adjuvant (A) | 2018-07-17 | 2019-03-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 99 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101789811 |
| 10390065 | 10071191 | 1.51 | 70.2 | Curative (C) | 2020-11-10 | 2020-11-13 | BORTEZOMIB + THALIDOMIDE | 02 | N | CISPLATIN | 101295404 |
| 10390166 | 10071192 | 1.56 | 78 | 03 | 2020-02-08 | 2021-04-23 | GEMCITABINE | 02 | null | CAPECITABINE + IRINOTECAN | 100576185 |
| 10390565 | 10071193 | 1.53 | 72.7 | null | 2019-05-20 | 2019-06-29 | CISPLATIN + RT | 02 | N | DABRAFENIB | 100055524 |
| 10392325 | 10071198 | null | 0 | null | 2022-04-12 | 2022-05-04 | MELPHALAN | 02 | null | MELPHALAN | 100748911 |
| 10392729 | 10071199 | 1.63 | 0 | null | 2019-03-15 | 2019-03-17 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 100025261 |
| 10393798 | 10071200 | 1.81 | 70.2 | Palliative (P) | 2021-08-20 | 2021-09-07 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100784295 |
| 10393881 | 10071201 | 1.61 | 59 | null | 2018-11-23 | 2019-01-07 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101109475 |
| 10394017 | 10071202 | 1.64 | 78.1 | null | 2020-04-02 | 2020-04-02 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100469794 |
| 10394092 | 10071203 | 1.66 | 71.6 | Palliative (P) | 2022-01-28 | 2022-03-05 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101218214 |
| 10394095 | 10071204 | 1.79 | 68.8 | null | 2019-01-04 | 2020-02-15 | CABOZANTINIB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101313413 |
| 10394555 | 10071206 | 1.7 | 71.4 | null | 2019-03-15 | 2019-03-16 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101766674 |
| 10395783 | 10071207 | 1.72 | 103 | Palliative (P) | 2022-03-04 | 2022-03-10 | PERTUZUMAB + TRASTUZUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100563493 |
| 10397323 | 10071209 | 1.72 | 71 | Palliative (P) | null | 2017-10-23 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101420043 |
| 10397511 | 10071210 | 1.76 | 73.3 | 03 | 2016-03-20 | 2018-05-16 | Bortezomib +/- Dexamethasone | null | N | BORTEZOMIB | 100559080 |
| 10398606 | 10071211 | 1.71 | 88.8 | null | 2018-03-29 | 2018-04-02 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101834453 |
| 10399803 | 10071213 | 1.61 | 100 | Palliative (P) | 2020-04-18 | 2020-04-18 | Cabazitaxel | 02 | N | CABAZITAXEL | 100479259 |
| 10403107 | 10071217 | 1.64 | 91.4 | null | 2017-11-15 | 2018-04-11 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 101573942 |
| 10404444 | 10071220 | 1.59 | 64.1 | Palliative (P) | 2021-02-19 | 2021-03-08 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101732737 |
| 10404614 | 10071221 | 1.68 | 108.6 | Neo-adjuvant (N) | 2019-07-19 | 2019-07-27 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101714696 |
| 10405992 | 10071222 | 1.75 | 62 | null | 2018-10-27 | 2018-11-10 | CISPLATIN + RT | 02 | null | CAPECITABINE + IRINOTECAN | 101791626 |